PRKN and type 2 diabetes mellitus: In our present study, we observed marked reduced p-AMPK Thr172 along with much lower expression levels of PINK1, Parkin and p-ULK1 in T2DM condition both in vivo and in vitro, while these changes were reversed by cav-1.